ATE414516T1 - Morphinanderivate als mittel gegen juckreiz - Google Patents

Morphinanderivate als mittel gegen juckreiz

Info

Publication number
ATE414516T1
ATE414516T1 AT05727323T AT05727323T ATE414516T1 AT E414516 T1 ATE414516 T1 AT E414516T1 AT 05727323 T AT05727323 T AT 05727323T AT 05727323 T AT05727323 T AT 05727323T AT E414516 T1 ATE414516 T1 AT E414516T1
Authority
AT
Austria
Prior art keywords
morphinan
morphinand
itching
remedy
derivatives
Prior art date
Application number
AT05727323T
Other languages
English (en)
Inventor
Naoki Izumimoto
Toshikazu Komagata
Toshiyuki Honda
Koji Kawai
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Application granted granted Critical
Publication of ATE414516T1 publication Critical patent/ATE414516T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
AT05727323T 2004-03-30 2005-03-30 Morphinanderivate als mittel gegen juckreiz ATE414516T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004097798 2004-03-30

Publications (1)

Publication Number Publication Date
ATE414516T1 true ATE414516T1 (de) 2008-12-15

Family

ID=35063503

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05727323T ATE414516T1 (de) 2004-03-30 2005-03-30 Morphinanderivate als mittel gegen juckreiz

Country Status (12)

Country Link
US (1) US7718664B2 (de)
EP (1) EP1736157B1 (de)
JP (1) JP4882744B2 (de)
KR (1) KR101233289B1 (de)
CN (1) CN100586434C (de)
AT (1) ATE414516T1 (de)
CA (1) CA2561509C (de)
DE (1) DE602005011113D1 (de)
ES (1) ES2317219T3 (de)
PT (1) PT1736157E (de)
TW (1) TW200533355A (de)
WO (1) WO2005094826A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200621785A (en) 2004-11-04 2006-07-01 Toray Industries Analgesic
EP1762569A1 (de) * 2005-09-12 2007-03-14 Alcasynn Pharmaceuticals Gmbh Neue 6-Amino-morphinanderivate, Herstellungsverfahren dafür und deren Verwendung als Analgetika
WO2007055184A1 (ja) * 2005-11-09 2007-05-18 Toray Industries, Inc. 機能性腸障害の治療または予防剤
EP1974731B1 (de) * 2005-12-21 2011-07-13 Toray Industries, Inc. Morphinanderivate zur verwendung als hustenmittel
FR2898124B1 (fr) * 2006-03-03 2008-09-12 Centre Nat Rech Scient Derive de resveratol a longue chaine hydroxylee utiles comme neurotrophiques
JP5564943B2 (ja) * 2007-05-21 2014-08-06 東レ株式会社 結晶性微粉化粒子
AU2008254039B2 (en) * 2007-05-21 2013-10-24 Toray Industries, Inc. Method for producing pharmaceutical tablet
AU2008254038B2 (en) * 2007-05-21 2013-01-10 Toray Industries, Inc. Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
CN101786990B (zh) * 2010-03-04 2012-01-18 合肥工业大学 一种具有抗痒活性的化合物
US20140179727A1 (en) 2012-12-14 2014-06-26 Trevi Therapeutics, Inc. Methods for treating pruritus
US8987289B2 (en) 2012-12-14 2015-03-24 Trevi Therapeutics, Inc. Methods for treating pruritus
US8637538B1 (en) 2012-12-14 2014-01-28 Trevi Therapeutics, Inc. Methods for treatment of pruritis
US20160361393A1 (en) * 2015-06-11 2016-12-15 Biostat Research, Llc Topical sting/bite formulation and method of use
AU2019229892A1 (en) 2018-03-08 2020-09-03 University Of Kansas Treatment of demyelinating diseases
EP3826635A4 (de) 2018-07-23 2022-04-27 Trevi Therapeutics, Inc. Behandlung von chronischem husten, kurzatmigkeit und dyspnoe

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4118826Y1 (de) 1964-01-24 1966-09-02
JPS4118823B1 (de) 1964-02-03 1966-10-31
JPS416905B1 (de) * 1964-02-03 1966-04-19
JPS417786B1 (de) * 1964-02-03 1966-04-25
US3318884A (en) * 1965-07-21 1967-05-09 American Cyanamid Co Substituted 6-amino-6-demethoxythebaine and 6-amino-6-demethoxyoripavine derivatives
EP0116538A4 (de) * 1982-08-25 1985-04-25 Joel E Bernstein Verfahren zur behandlung von pruritis und zusammensetzung dazu.
ES2236630T3 (es) 1996-11-25 2005-07-16 Toray Industries, Inc. Agente antipruritico.
US5760023A (en) * 1997-07-14 1998-06-02 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
EP0996434A4 (de) * 1997-07-14 2001-10-10 Adolor Corp Kappa-rezeptor agonisten enthaltende antipruritische arzneimittel und verfahren zur behandlung von pruritis
JP4370683B2 (ja) * 2000-05-08 2009-11-25 東レ株式会社 そう痒疾患の検査方法
JP2002308769A (ja) 2001-04-12 2002-10-23 Toray Ind Inc 止痒剤
WO2004033457A1 (ja) * 2002-10-09 2004-04-22 Toray Industries, Inc. 頻尿もしくは尿失禁の治療または予防剤および含窒素環状置換基を有するモルヒナン誘導体
JP4656081B2 (ja) * 2002-10-09 2011-03-23 東レ株式会社 含窒素環状置換基を有するモルヒナン誘導体
JP4118823B2 (ja) 2003-11-10 2008-07-16 シャープ株式会社 画像処理装置、画像形成装置、画像処理方法、画像処理プログラム、および記録媒体
JP4118824B2 (ja) 2004-02-24 2008-07-16 株式会社日立製作所 優先パケットの遅延を最小化するシェーピング装置
JP4118826B2 (ja) 2004-03-01 2008-07-16 リオン株式会社 補聴器用ケースなどの製造方法及びその装置

Also Published As

Publication number Publication date
DE602005011113D1 (de) 2009-01-02
TW200533355A (en) 2005-10-16
EP1736157A1 (de) 2006-12-27
KR20060132953A (ko) 2006-12-22
ES2317219T3 (es) 2009-04-16
CN1938028A (zh) 2007-03-28
CA2561509C (en) 2012-08-28
PT1736157E (pt) 2008-12-31
EP1736157A4 (de) 2007-06-13
US20080275074A1 (en) 2008-11-06
CA2561509A1 (en) 2005-10-13
EP1736157B1 (de) 2008-11-19
JP4882744B2 (ja) 2012-02-22
US7718664B2 (en) 2010-05-18
WO2005094826A1 (ja) 2005-10-13
KR101233289B1 (ko) 2013-02-14
JPWO2005094826A1 (ja) 2008-02-14
CN100586434C (zh) 2010-02-03

Similar Documents

Publication Publication Date Title
ATE414516T1 (de) Morphinanderivate als mittel gegen juckreiz
MXPA06009475A (es) Derivados de quinazolina y usos terapeuticos de los mismos.
EA200801998A1 (ru) ПИРИДИН[3,4-b]ПИРАЗИНОНЫ
BR0312934A (pt) Derivados de 8-hidróxi quinolina
EA200600892A1 (ru) Новые хинолиновые производные
MY132566A (en) Benzimidazolone histamine h3 antagonists
BR0308452A (pt) composições farmacêuticas e métodos de preparação de composição farmacêutica
EA200500814A1 (ru) Производные пирролопиримидина
PT2385053E (pt) Intermediários para a preparação de compostos bicíclicos condensados como inibidores mtor
HK1119699A1 (en) Pyridopyrimidinone inhibitors of pi3kalpha
WO2001066534A3 (en) Cyclic and bicyclic diamino histamine-3 receptor antagonists
UA84712C2 (en) N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
GB0413087D0 (en) Therapeutic compounds
DE69838662D1 (de) Morphinanderivate und ihre medizinische Anwendung
BR0307058A (pt) N-óxidos de derivados de n-fenil-2-pirimidina-amina
WO2006113552A3 (en) Cyanoarylamines
NO20054787D0 (no) Indenderivater som farmasotiske midler
ATE466842T1 (de) 3-substituierte pyridinderivate als h3- antagonisten
DK1543010T3 (da) N-substituerede hydromorphoner og anvendelse deraf
IL191751A0 (en) Pyrrolo[2,3-c]pyridine derivatives
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
NO20080033L (no) Kinolinderivater som NK3-antagonister
RS20060280A (en) Novel keto-oxadiazole derivatives as cathepsin inhibitors
TW200621785A (en) Analgesic
TW200806294A (en) Therapeutic or prophylactic agent for functional intestinal injury

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1736157

Country of ref document: EP

REN Ceased due to non-payment of the annual fee